ABOUT EAGLENOS

With an investment of $ 25 million, Eaglenos has been steadily expanding and so far has built a R&D base of more than 7500+ square meters in the state-level high-tech zone, Jiangbei New Area that consists of international standard R&D labs, GMP manufacturing workshops, automated production lines.

Nanjing Eaglenos Co., Ltd.

Nanjing-based Eaglenos was founded in 2018, with a dedicated team of top domestic talents in fields like chemical, material, machinery, electronics, software, biomedical engineering.Quality, Innovation, Cooperation, Accountability run through our DNA. We are dedicated to technology innovation in electrochemical, microfluidics, signal collection and automation and has launched a series of POCT products targeting multiple diseases like diabetes, hyperuricemia, cardiovascular.

With an investment of $ 25 million, Eaglenos has been steadily expanding and so far has built a R&D base of more than 7500+ square meters in the state-level high-tech zone, Jiangbei New Area that consists of international standard R&D labs, GMP manufacturing workshops, automated production lines.The past four years of continuous investment have seen three product platforms, including cartridge testing, paper-strip testing and dynamic monitoring. As a provider of high-quality products and services, Eaglenos would continue to diversify our products on accurate detection in a broader effort to be a reliable human health guardian.

Who We Are

2018 year

Establishing Time

7500+

Site Area

200+

Educated Employees

OUR CULTURE

Our Vision

Advance personalized health management through precision measurements and technology innovation to become the guardian of human well-being.

Our Mission

We innovate health management

Our Value

Q uality
I nnovation
C ooperation
A ccountablility